Industry News, Content and Resources
RWE Solutions Market Predicted to Reach $78.83 Billion by 2030
The global Real World Evidence (RWE) Solutions Market is projected to grow substantially, from USD 43.22 billion in 2022 to USD 78.83 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 7.8%. This growth is driven by the rising adoption of RWE solutions in [...]
3 Billion Data Points Inform Verantos’ IBD Registry for Advanced Patient Care Research
Verantos, a leader in real-world evidence, has launched their Inflammatory Bowel Disease (IBD) Pragmatic Registry, which offers in-depth data on patients with ulcerative colitis and Crohn's disease. This registry integrates both unstructured and structured data from electronic health records, claims, and mortality data, providing a comprehensive [...]
Eleos Technology Cuts Documentation Time and Enhances Care Quality
Eleos, founded by Dror Zaide, uses innovative technology to streamline documentation for behavioral health providers, shortening the documentation process by 50%. In an interview with Behavioral Health Business, Zaide, a former Israeli Air Force drone pilot with personal connections to mental health challenges, details how this [...]
Partnership Between Parexel and Palantir to Enhance Clinical Trials
Parexel, a leading clinical research organization, has partnered with Palantir Technologies with the intent of using AI to improve clinical trials for biopharmaceutical clients. Parexel will integrate Palantir's Foundry and AI Platform into its clinical data system to enhance trial efficiency while maintaining safety and regulatory [...]
$9.75M Commons Clinic Investment Revolutionizes Orthopedic Treatment
Commons Clinic is helping reshape orthopedic healthcare by investing $9.75M in Marina Orthopedic & Spine Institute (MOSI) and launching Theater, a technology platform. This investment further expands Commons Clinic's network of Ambulatory Surgery Centers (ASCs), aligning with a trend towards outpatient procedures that is expected to [...]
Reducing Medication Errors in Cancer Treatment with Insights from the AMBORA Trial
A recent publication from Cuba et al. highlights the AMBORA trial, which demonstrated how common medication errors are in cancer patients receiving oral antitumor therapies, and how these errors can be reduced with focused clinical pharmacological/pharmaceutical care programs. This trial compared the frequency and nature of [...]
Ibrutinib’s Success in CLL Treatment: Supported by Real World Data
Final results are in from the EVIdeNCE study, which analyzed 309 chronic lymphocytic leukemia (CLL) patients in Italy treated with ibrutinib (Imbruvica; AbbVie/Pharmacyclics), reaffirming the efficacy and safety previously shown in clinical trials. Despite a significant number of patients with cardiovascular comorbidities, these conditions did not [...]
EU Probes China’s Medical Device Market Access
The European Commission has initiated an investigation into China's public procurement practices for medical devices, increasing trade tensions ahead of President Xi Jinping's visit to Europe. This investigation, the first under the EU International Procurement Instrument (IPI), seeks to determine if European suppliers are being fairly [...]
Implications for Medical Affairs Teams in 2024 and Beyond
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They navigate challenges in organizational transformation, artificial intelligence (AI) integration, and omnichannel engagement. Transforming organizational structures involves alignment with broader goals and excelling in scientific engagement. AI offers potential to streamline [...]
Aerial Contagion: Redefining Airborne Pathogens
The World Health Organization (WHO) has recently announced a revision of its classification of airborne pathogens, including SARS-CoV-2, after criticism of delayed recognition during the pandemic. The WHO's technical report replaces the previous three categories of viral transmission airborne, droplet, and aerosol, with "infectious respiratory particles". [...]
ImmunityBio’s Combination Therapy Approved for Bladder Cancer
The U.S. Food and Drug Administration (FDA) has recently approved ImmunityBio's combination therapy for vaccine-resistant bladder cancer. As this condition affects 75-85% of bladder cancer patients, finding suitable therapies is urgent. This approval is a exciting turnaround for the company, which previously faced FDA rejection due [...]
Bridging Urban-Rural Healthcare Gaps Through Real-World Data
Medical research and clinical trials have historically favored urban communities, resulting in an underrepresentation of rural communities. Real-world data (RWD) gathered from sources like electronic health records offers insights that transcend geographic limitations, revealing how factors like limited access to healthcare impact the health outcomes of [...]
Chiesi Focuses on Patient-Centered Care in Fabry Disease
Chiesi Global Rare Diseases has published survey results in the Orphanet Journal of Rare Diseases that underscore the persistent awareness gap and unique struggles of rare disease patients, specifically those with Fabry disease. Giacomo Chiesi emphasizes the importance of understanding the disease from a patient's viewpoint [...]
ISPOR 2024: Keynote Speakers and Sessions Announced
The ISPOR 2024 conference, a key event for Health Economics and Outcomes Research (HEOR), will take place from May 5th to 8th in Atlanta, Georgia. This global gathering, of which is expected to draw nearly 5000 participants, will explore the theme "HEOR: A Transformative Force for [...]
Forecast of the Global Real World Evidence (RWE) Solutions Market
The Global Real World Evidence (RWE) Solutions Market is forecasted to grow from 2.7 billion (USD) in 2023 to 5.8 billion by 2033, with a CAGR of 7.9% from 2024 to 2033, as per Market.us. This growth is driven by the increasing utility of RWE in strategic [...]